Polymer Manufacturer Invibio Settles Monopoly Claims

15 Jul 2016
News

Elizabeth Orr @elizabethjorr elizabeth.orr@informa.com

Executive Summary

The US Federal Trade Commission said the company, which supplies more than 90% of a certain type of high-quality plastic used in medical implants, used exclusivity clauses in its contracts to keep competitors out of the market and illegally maintain its monopoly. An FTC final consent order was announced July 14.

Already Registered? Sign in to continue reading.

New to Medtech Insight? Start a free trial today!

Table
View full table

Topics

Regions
North America

United States

Industries
Medical Device
Subjects
Commercial
Regulation
Companies
Device Areas
Orthopedics

Related Companies

ASK THE ANALYST
Email

Print
Bookmark
Share

Tags:

United States Medical Device Commercial

You must sign in to use this functionality

Authentication.SignIn.HeadSignInHeader

MT103603

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel

MT103603

All set! This article has been sent to my@email.address.

All fields are required. For multiple recipients, separate email addresses with a semicolon.

Please Note: Only individuals with an active subscription will be able to access the full article. All other readers will be directed to the abstract and would need to subscribe.

Polymer Manufacturer Invibio Settles Monopoly Claims

News

Executive Summary

Topics

Related Companies

You must sign in to use this functionality

Authentication.SignIn.HeadSignInHeader

Register

Ask The Analyst

Email Article

Sign In To Set a Search Alert